Phase II Trial of Weekly Docetaxel and Four Weekly Carboplatin Combination in the First-Line Treatment of Advanced Non-Small Cell Lung Cancer.
Phase of Trial: Phase II
Latest Information Update: 26 Jul 2010
At a glance
- Drugs Carboplatin; Docetaxel
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Acronyms Carbo-Tax
- Sponsors Sanofi
- 12 Jan 2010 Actual end date (Jul 2009) added as reported by ClinicalTrials.gov.
- 12 Jan 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 25 Jan 2009 New trial record.